Table 3.

Cardiometabolic markers of participants before and after intervention.

	Magnesium-supplemented group				Placebo group				Difference
	Before	After	Mean difference ± SE	P value*	Before	After	Mean difference ± SE	P value*	P value**
SBP (mmHg)	120.0 ± 20.1	115.7 ± 12.8	− 4.2 ± 4.03	0.30	120.5 ± 13.3	113 ± 24.5	− 7.5 ± 3.7	0.05	0.55
DBP (mmHg)	76.8 ± 13.1	73.9 ± 9.2	− 2. ± 3.2	0.38	79.2 ± 15.7	74.1 ± 13.0	− 5.1 ± 3.2	0.12	0.98
Total-C (mg/dL)	193.1 ± 37.5	188.2 ± 38.7	− 4.9 ± 8.7	0.58	183.6 ± 40.8	176.9 ± 35.5	− 6.7 ± 6.6	0.32	0.36
TG (mg/dL)	156.4 ± 77.9	123.1 ± 48.4	− 33.3 ± 14.0	0.02	158.0 ± 65.3	135.7 ± 51.7	− 22.3 ± 8.9	0.01	0.28
HDL-C (mg/dL)	46.0 ± 11.8	49.7 ± 10.9	3.7 ± 1.1	0.002	42.9 ± 7.8	43.6 ± 7.2	0.7 ± 0.7	0.29	0.003
LDL-C (mg/dL)	99.9 ± 27.3	95.0 ± 24.1	− 4.9 ± 5.3	0.37	97.7 ± 27.4	88.2 ± 22.2	− 9.5 ± 4.2	0.03	0.25
HbA1c (%)	5.8 ± 0.7	6.6 ± 0.8	0.8 ± 0.1	< 0.001	5.8 ± 0.6	6.5 ± 0.8	0.7 ± 0.1	< 0.001	0.55
FPG (mg/dL)	115.1 ± 14.2	116.5 ± 13.7	− 1.5 ± 2.0	0.48	112.5 ± 12.2	111.8 ± 14.3	− 0.7 ± 1.8	0.72	0.29
FPI (μU/mL)	8.2 ± 5.9	16.9 ± 7.8	8.7 ± 1.4	< 0.001	14.8 ± 9.6	17.9 ± 8.4	3.2 ± 1.3	0.02	0.18
Uric acid (mg/dL)	5.2 ± 1.4	4.9 ± 1.1	− 0.2 ± 0.2	0.28	4.8 ± 1.1	5.1 ± 1.0	0.26 ± 0.1	0.04	0.09
CRP (mg/L)	1.3 ± 2.7	3.1 ± 4.0	1.8 ± 0.5	0.001	1.3 ± 2.6	2.2 ± 2.1	0.8 ± 0.4	0.03	0.10
HOMA-IR index	3.1 ± 4.4	4.9 ± 2.5	1.8 ± 0.9	0.06	4.0 ± 2.8	4.9 ± 2.6	0.9 ± 0.4	0.02	0.80

SBP systolic blood pressure, DBP diastolic blood pressure, C cholesterol, TG triglyceride, FPG fasting plasma glucose, fasting plasma insulin, CRP C-reactive protein.

*Resulted from paired t-test for comparing mean values of outcomes before and after intervention in each study group.

**Resulted from ANCOVA for comparing two study groups based on mean values of outcomes after intervention and adjustment for baseline values.